Article thumbnail

Characterization of the Biosynthesis, Processing and Kinetic Mechanism of Action of the Enzyme Deficient in Mucopolysaccharidosis IIIC

By Xiaolian Fan, Ilona Tkachyova, Ankit Sinha, Brigitte Rigat and Don Mahuran


Heparin acetyl-CoA:alpha-glucosaminide N-acetyltransferase (N-acetyltransferase, EC is an integral lysosomal membrane protein containing 11 transmembrane domains, encoded by the HGSNAT gene. Deficiencies of N-acetyltransferase lead to mucopolysaccharidosis IIIC. We demonstrate that contrary to a previous report, the N-acetyltransferase signal peptide is co-translationally cleaved and that this event is required for its intracellular transport to the lysosome. While we confirm that the N-acetyltransferase precursor polypeptide is processed in the lysosome into a small amino-terminal alpha- and a larger ß- chain, we further characterize this event by identifying the mature amino-terminus of each chain. We also demonstrate this processing step(s) is not, as previously reported, needed to produce a functional transferase, i.e., the precursor is active. We next optimize the biochemical assay procedure so that it remains linear as N-acetyltransferase is purified or protein-extracts containing N-acetyltransferase are diluted, by the inclusion of negatively charged lipids. We then use this assay to demonstrate that the purified single N-acetyltransferase protein is both necessary and sufficient to express transferase activity, and that N-acetyltransferase functions as a monomer. Finally, the kinetic mechanism of action of purified N-acetyltransferase was evaluated and found to be a random sequential mechanism involving the formation of a ternary complex with its two substrates; i.e., N-acetyltransferase does not operate through a ping-pong mechanism as previously reported. We confirm this conclusion by demonstrating experimentally that no acetylated enzyme intermediate is formed during the reaction

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1993). A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease
  2. (1978). A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients.
  3. (2010). A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates.
  4. (1985). Acteyl Coenzyme A: alpha-Glucosaminide NAceyltransferase: Evidence for a transmembrane acetylation mechanism.
  5. (2006). An acetylated 120-kDa lysosomal transmembrane protein is absent from mucopolysaccharidosis IIIC fibroblasts: a candidate molecule for MPS IIIC.
  6. (2010). Analysis of the Biogenesis of Heparan Sulfate Acetyl-CoA: {alpha}-Glucosaminide N-Acetyltransferase Provides Insights into the Mechanism Underlying Its Complete Deficiency in Mucopolysaccharidosis IIIC.
  7. (1998). Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders.
  8. (1980). Biosynthesis of lysosomal enzymes in fibroblasts: synthesis as precursors of higher molecular weight.
  9. (2007). Catalytic mechanism of a MYST family histone acetyltransferase.
  10. (1991). Characterization of human placental ß-hexosaminidase I2: Proteolytic processing intermediates of hexosaminidase A.
  11. (2003). Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
  12. (2006). Crystallographic Structure of Human beta-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of G(M2) Ganglioside Hydrolysis.
  13. (2009). Detergent binding explains anomalous SDS-PAGE migration of membrane proteins.
  14. (2010). Functional analysis of the HGSNAT gene in patients with mucopolysaccharidosis
  15. (1986). Genetic evidence for transmembrane acetylation by lysosomes.
  16. (2006). Highthroughput screening for novel human lysosomal beta-N-acetyl hexosaminidase inhibitors acting as pharmacological chaperones.
  17. (1995). Human acetyl-coenzyme A:alphaglucosaminide N-acetyltransferase. Kinetic characterization and mechanistic interpretation.
  18. (2009). Identification and characterization of ambroxol as an enzyme-enhancement agent for gaucher disease.
  19. (2006). Identification of the gene encoding the enzyme deficient in
  20. (2007). Lending a helping hand, screening chemical libraries for compounds that enhance ß-hexosaminidase A activity in GM2 Gangliosidosis cells.
  21. (2010). Mannose phosphorylation in health and disease.
  22. (2010). Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles. Clinical Genetics;in press.
  23. (2008). Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.
  24. (2006). Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome).
  25. (1986). Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
  26. (1994). Prenatal diagnosis of Sanfilippo disease type C using a simple fluorometric enzyme assay.
  27. (2009). Protein misfolding as an underlying molecular defect in mucopolysaccharidosis III type C.
  28. (1988). Proteolytic processing of the alpha chain of the lysosomal enzyme ß-hexosaminidase, in normal human fibroblasts.
  29. (1989). Proteolytic processing of the ß-subunit of the lysosomal enzyme, ß-hexosaminidase, in normal human fibroblasts.
  30. (2009). Proteomics of the lysosome.
  31. (2010). Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor.
  32. (1978). Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.
  33. (2009). Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene.
  34. (2003). Signals for sorting of transmembrane proteins to endosomes and lysosomes.
  35. (2002). Stability of the lactose permease in detergent solutions.
  36. (1992). The early and late processing of lysosomal enzymes: proteolysis and compartmentation.
  37. (1991). The human GM2 activator protein. A substrate specific cofactor of ß-hexosaminidase A.
  38. (2008). The mannose 6-phosphate glycoprotein proteome.
  39. (2001). The Mucopolysaccharides. In:
  40. (1980). The subunit and polypeptide structure of hexosaminidase from human placenta.